scanX
Kopran

Kopran

166.09
-1.09
(-0.65%)
hide
Key Fundamentals
Add Ratio
Market Cap
807.30 Cr
EPS
7.99
PE Ratio
23.02
Dividend Yield
1.80 %
Industry
Healthcare
52 Week High
329.00
52 Week Low
154.06
PB Ratio
1.55
Debt to Equity
0.24
Sector
Pharmaceuticals
Forecast For
Actual

Company News

View All News
Caret
neutral
Kopran Limited: Promoter Group Share Transactions Under SEBI RegulationsSep 15, 2025
Kopran Limited disclosed share transactions within its promoter group under SEBI regulations. Surendra Somani acquired 35,635 shares through an off-market transaction, increasing his holding from 9,27,975 shares (1.92%) to 9,63,610 shares (2.00%). Simultaneously, Kumkum Somani sold 35,635 shares, reducing her holding from 35,635 shares (0.07%) to zero shares. The transactions occurred between promoter group members, with the company's total equity share capital remaining at INR 48.28 crores. Other promoter group entities including Vandana Somani, Varun Somani, Oriental Enterprises Partnership Firm, Panorama Finvest Private Ltd, Parijat Shipping and Finale Limited, and Sarvamangal Mercantile Company Limited maintained their existing shareholdings.
neutral
Kopran Limited Promoter Group Completes Share Transfer TransactionsSep 10, 2025
Kopran Limited's promoter group members completed off-market share transfer transactions. In the first transaction, Mridula Somani, Nupur Somani, and Adarsh Somani transferred their combined holdings of 12,39,650 shares (2.57% of total voting capital), reducing their holdings to zero. In the second transaction, Hridai Somani, Jaya Somani, Suhrid Somani, and Susheel G Somani transferred 7,40,700 shares (1.53% of total voting capital), also reducing their individual holdings to zero. Kumkum Somani retained 35,635 shares (0.07%). The company's equity share capital remained unchanged at INR 48.28 crores before and after both transactions.
positive
KOPRAN Co-Promoters Finalize Family Agreement To Strengthen Management ControlSep 02, 2025
KOPRAN's co-promoters have finalized a family agreement aimed at strengthening management control of the company.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
Divis Laboratories
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
Cipla
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
Torrent Pharmaceuticals
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
Dr Reddys Laboratories
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
Mankind Pharma
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
Zydus Life Science
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
Lupin
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
Alkem Laboratories
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
Aurobindo Pharma
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
0.70 %
Net Income Growth
-24.31 %
Cash Flow Change
-3.05 %
ROE
-28.25 %
ROCE
-23.91 %
EBITDA Margin (Avg.)
-14.28 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
61
78
76
78
66
82
82
100
54
75
99
98
62
92
107
104
87
89
102
88
124
125
116
145
78
130
136
145
126
117
160
153
119
153
161
196
142
153
166
176
138
Expenses
58
72
71
68
59
72
69
82
48
66
85
86
57
82
90
88
77
77
88
77
101
98
91
121
66
104
105
117
113
107
146
137
111
130
135
164
121
137
146
155
121
EBITDA
4
6
5
11
7
10
12
18
6
9
13
12
5
10
18
16
10
12
14
11
24
27
25
24
12
27
31
28
14
11
15
16
9
23
26
31
21
16
20
20
17
Operating Profit %
6 %
8 %
4 %
13 %
7 %
9 %
13 %
15 %
7 %
10 %
10 %
11 %
6 %
11 %
15 %
12 %
9 %
12 %
12 %
12 %
17 %
18 %
19 %
14 %
12 %
19 %
21 %
18 %
10 %
9 %
8 %
8 %
5 %
15 %
15 %
12 %
13 %
10 %
12 %
10 %
10 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
Interest
3
3
3
3
3
4
3
4
3
2
2
2
2
3
2
2
2
2
3
2
2
1
2
1
1
1
2
1
1
1
2
2
2
2
2
3
2
2
2
3
3
Profit Before Tax
1
3
2
5
2
5
7
11
1
5
10
8
1
5
13
12
6
8
9
7
19
23
21
20
8
23
27
24
10
6
9
11
4
18
21
25
15
10
14
14
10
Tax
0
0
0
0
0
0
0
5
0
0
0
2
0
1
3
4
1
2
2
2
5
6
5
5
2
6
7
7
2
1
2
3
1
5
5
7
4
2
4
4
2
Net Profit
1
3
2
5
2
5
7
6
1
5
10
5
1
4
11
8
4
6
6
5
14
17
16
15
6
17
20
18
8
5
7
8
3
14
16
19
11
7
10
10
7
EPS in ₹
0.14
0.69
0.52
1.21
0.48
1.04
1.68
1.39
0.24
1.05
2.27
1.19
0.27
0.99
2.51
1.78
0.95
1.31
1.46
1.11
3.29
3.84
3.63
3.48
1.47
3.95
4.64
3.68
1.58
0.97
1.44
1.67
0.58
2.86
3.28
3.86
2.30
1.53
2.16
2.01
1.54
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
275
264
298
316
352
371
439
611
650
743
844
Fixed Assets
102
101
105
104
113
111
112
151
165
182
208
Current Assets
170
154
180
194
208
223
277
415
399
454
510
Capital Work in Progress
1
3
6
10
24
30
43
36
70
97
113
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
172
160
187
201
215
230
284
425
415
465
522
Total Liabilities
275
264
298
316
352
371
439
611
650
743
844
Current Liabilities
158
122
137
136
135
140
161
152
177
219
289
Non Current Liabilities
18
33
37
35
49
42
34
33
34
34
37
Total Equity
99
109
125
145
169
190
245
426
439
491
518
Reserve & Surplus
35
57
81
102
125
146
202
378
391
443
470
Share Capital
50
52
43
43
43
43
43
48
48
48
48
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
0
-0
-0
0
0
0
5
2
1
11
Investing Activities
-10
-9
-18
-11
-25
-13
-25
-84
-13
-44
-56
Operating Activities
46
29
16
26
25
31
60
-34
34
43
42
Financing Activities
-37
-19
2
-15
-1
-18
-35
123
-20
1
26
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Jan 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
43.78 %
43.78 %
43.78 %
43.78 %
44.25 %
44.25 %
44.25 %
44.25 %
44.30 %
44.30 %
44.49 %
44.49 %
44.49 %
44.49 %
44.49 %
44.49 %
44.46 %
44.42 %
44.42 %
44.42 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.48 %
0.84 %
0.68 %
1.32 %
0.86 %
1.12 %
0.76 %
0.60 %
DIIs
1.97 %
0.53 %
0.46 %
0.16 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.35 %
0.14 %
1.20 %
0.14 %
0.22 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.93 %
40.67 %
40.71 %
40.62 %
40.68 %
39.78 %
39.89 %
39.53 %
39.51 %
39.05 %
39.15 %
40.45 %
39.90 %
37.98 %
39.69 %
40.74 %
41.35 %
41.36 %
42.83 %
44.65 %
Others
12.32 %
15.02 %
15.06 %
15.45 %
14.93 %
15.83 %
15.72 %
16.08 %
16.05 %
16.52 %
16.22 %
14.71 %
14.99 %
15.49 %
15.01 %
13.23 %
13.32 %
13.10 %
11.99 %
10.33 %
No of Share Holders
35,833
40,512
38,195
37,822
39,031
39,906
40,883
41,768
42,034
41,567
44,038
53,791
51,636
50,850
51,492
57,154
60,560
58,652
60,194
62,222

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 3 3 3 3 3
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 1.07 2.97 1.16 1.71 1.81

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 Aug 2021 DIVIDEND Dividend
₹ 1.50 /share
 05 Aug 2021 207.10 220.20
08 Aug 2022 DIVIDEND Dividend
₹ 3.00 /share
 04 Aug 2022 222.90 200.00
08 Sept 2023 DIVIDEND Dividend
₹ 3.00 /share
 07 Sept 2023 145.40 241.85
03 Sept 2024 DIVIDEND Dividend
₹ 3.00 /share
 02 Sept 2024 249.25 294.55
11 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Sept 2024 274.95 348.40
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Nov 2024 291.15 293.10
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Feb 2025 180.15 178.39
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 15 May 2025 180.05 193.15
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Jul 2025 180.80 177.30
04 Sept 2025 DIVIDEND Dividend
₹ 3.00 /share
 04 Sept 2025 193.15 173.15
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Sept 2025 177.30 182.25

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 15, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 09, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 08, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 02, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Aug 25, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Aug 25, 2025
Reg. 34 (1) Annual Report.Aug 16, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 16, 2025
Corporate Action-Board to consider DividendAug 11, 2025
Intimation Of Record Date For Dividend PaymentAug 11, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 29, 2025
Unaudited Results For Quarter Ended June 2025Jul 29, 2025
Board Meeting Intimation for Results Q1 FY 2025-26Jul 18, 2025
Closure of Trading WindowJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Board Meeting Outcome for Final Dividend For FY 2024-25May 15, 2025
Board Meeting Outcome for Final Dividend For FY 2024-25May 15, 2025
Audited Financial Results For The Quarter And Year Ended March 31 2025May 15, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMay 13, 2025
Board Meeting Intimation for Audited Financial Results Q4 2024-25May 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementApr 18, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 27, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 21, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 20, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 20, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 20, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMar 18, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Financial Result Q3 FY 2024-25Feb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.04%
-11
0.01%
0.01%

Technical Indicators

RSI(14)
Neutral
41.25
ATR(14)
Less Volatile
5.34
STOCH(9,6)
Oversold
10.39
STOCH RSI(14)
Oversold
6.46
MACD(12,26)
Bearish
-1.43
ADX(14)
Weak Trend
14.66
UO(9)
Bearish
30.79
ROC(12)
Downtrend And Accelerating
-4.74
WillR(14)
Oversold
-97.28
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Fundamental Screeners
Price & Volume Screeners
Candlestick Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104